A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation

被引：0
|
作者：
Masahiko Fukatsu
Takenobu Murakami
Hiroshi Ohkawara
Shunichi Saito
Kazuhiko Ikeda
Suguru Kadowaki
Itaru Sasaki
Mari Segawa
Tomoko Soeda
Akihiko Hoshi
Hiroshi Takahashi
Akiko Shichishima-Nakamura
Kazuei Ogawa
Yoshihiro Sugiura
Hitoshi Ohto
Yasuchika Takeishi
Takayuki Ikezoe
Yoshikazu Ugawa
机构：
[1] Fukushima Medical University,Department of Neurology
[2] Fukushima Medical University,Department of Hematology
[3] Fukushima Medical University,Department of Blood Transfusion and Transplantation Immunology
[4] Fukushima Medical University,Department of Cardiovascular Medicine
[5] Fukushima Medical University,Fukushima Global Medical Science Center, Advanced Clinical Research Center
来源：
BMC Neurology | / 17卷
关键词：
Myasthenia gravis; Hematopoietic cell transplantation; Graft-versus-host disease; Regulatory T cells; Rituximab; Anti-acetylcholine receptor antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Bulbar presentation of myasthenia gravis with positive anti acetylcholine receptor antibody
    Gomez, R. S.
    Pacheco, J. A. S.
    Lima, D. V. E. S.
    Martins, D. D. C.
    Martins, J. C. C.
    Costa, A. A. S.
    Teliz, M. A. M.
    Fonseca, M. C.
    Santos, T. M.
    Silva, T. H. S.
    Braga, T. E. R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E342 - E342
  • [32] Neuronal intranuclear inclusion disease showing blepharoptosis and positive serum anti-acetylcholine receptor antibody without myasthenia gravis
    Hayashi, Koji
    Hamaguchi, Tsuyoshi
    Sakai, Kenji
    Nakamura, Keiko
    Wakabayashi, Koichi
    Shirasaki, Hiroe
    Yamada, Masahito
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 400 : 119 - 121
  • [33] Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
    Lien, Pei-Wen
    Joshi, Mrinmayee
    Tice, Jeffrey A.
    Agboola, Foluso
    Nikitin, Dmitriy
    Withanawasam, Vinura
    Jatoi, Saira
    Touchette, Daniel R.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (06): : 517 - 527
  • [34] ENHANCED LABORATORY DETECTION OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY CONTRIBUTES TO RISING INCIDENCE MYASTHENIA GRAVIS
    Mousavi, Ali
    Oger, Joel
    Kumar, Pankaj
    Aziz, Tariq
    Sodhi, Harvir
    Kaur, Navpreet
    Pakzad, Zahra
    Frykman, Hans
    MUSCLE & NERVE, 2024, 70 (03) : 657 - 658
  • [35] ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY IN MYASTHENIA-GRAVIS - RELATIONSHIP TO DISEASE SEVERITY AND EFFECT OF THYMECTOMY
    MATSUBARAMORI, F
    OHTA, M
    OHTA, K
    NISHITANI, H
    HAYASHI, K
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 1987, 3 (03) : 265 - 275
  • [36] Anti-acetylcholine receptor CD4+ T cells in myasthenia gravis:: Epitope repertoire and T cell receptor gene usage
    Conti-Fine, BM
    Wang, ZY
    Raju, R
    Howard, JF
    Navaneetham, D
    MYASTHENIA GRAVIS: DISEASE MECHANISM AND IMMUNOINTERVENTION, 2000, : 73 - 93
  • [37] Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis
    Nishida, Y.
    Takahashi, Y. K.
    Kanai, T.
    Nose, Y.
    Ishibashi, S.
    Sanjo, N.
    Uzawa, A.
    Oda, F.
    Ozawa, Y.
    Kuwabara, S.
    Noguchi, E.
    Suzuki, S.
    Nakahara, J.
    Suzuki, N.
    Ogawa, T.
    Yokoyama, K.
    Hattori, N.
    Konno, S.
    Fujioka, T.
    Kawaguchi, N.
    Hatanaka, Y.
    Sonoo, M.
    Kaneko, J.
    Ogino, M.
    Nishiyama, K.
    Nomura, K.
    Yokota, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (01) : 100 - 104
  • [38] Efficacy and safety of eculizumab in patients with anti-acetylcholine receptor antibody positive generalized refractory myasthenia gravis previously treated with rituximab
    Patti, F.
    Mozaffar, T.
    Yountz, M.
    O'brien, F.
    Siddiqi, Z.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 324 - 325
  • [39] Reduction rate of anti-acetylcholine receptor antibody titer levels is an early prognostic indicator for myasthenia gravis
    Hamada, Yasuhiro
    Deguchi, Kazushi
    Takaba, Keita
    Kawakita, Rie
    Takata, Tadayuki
    Morishita, Asahiro
    Kobara, Hideki
    Masaki, Tsutomu
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2024, 12 (03): : 180 - 186
  • [40] Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis
    Luo, Lijun
    Zhu, Xinyi
    Wen, Chunbei
    Guo, Yifan
    Yang, Jie
    Wei, Dongsheng
    Yu, Ping
    Wan, Mei
    FRONTIERS IN NEUROLOGY, 2025, 15
12345